A robust patent portfolio with long term protection of proprietary manufacturing processes and critical technologies across the U.S., EU, and Asia.

Enables personalized precision medicine by optimizing aerosol output and lung deposition. Integrated with data driven monitoring to reduce drug waste and improve therapeutic outcomes.
Propellant free microfluidic nozzle technology creates fine, controlled aerosol clouds through liquid-column impaction, enabling sustained-release inhalation therapies.
Lower contamination risk, portable power compatibility, and flexible deployment for emergency and mobile healthcare scenarios.
Strategic Patent Intelligence
Real time monitoring of technology trends and competitive dynamics enables precise patent positioning in forward looking fields, including smart nebulizers, specialized nebulization modules (e.g. high viscosity or high / Low shear drugs), and core components for industrial inkjet print heads.
Systematic analysis of product technology evolution and innovation pathways helps companies identify future opportunities in both red ocean and blue ocean markets.
Maintenance & Defensive Strategy
A global patent benchmarking and monitoring system supports cross border patent defense and risk tracking. AI-driven risk identification protects existing product advantages while reducing legal and commercial exposure.
Through an end-to-end CDMO (Contract Development and Manufacturing Organization) model covering R&D, process development, validation, regulatory submission, and market entry, MicroBase helps clients reduce development costs and technical risks, accelerate global regulatory approval, and transform innovation into commercially viable assets.